Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.
UCB’s 90-year book is a goldmine to discover!
Twitter Feed
-
UCB is recruiting talents to grow our global IT team. Are you curious to hear what it's like to be a part of it? See the testimonial of Arena. https://t.co/RWS68tYsFH https://t.co/uMuL1l3TLP
— UCB News (@ucb_news) 21.02.2019 -
In order to achieve patient-centred healthcare it is important to focus on what we have in common and collaborate: pharmaceutical companies, payers and other healthcare system stakeholders. All should have a shared goal of maximising #value to patients. #
— UCB News (@ucb_news) 21.02.2019 -
“We are passionate about collaboration with other healthcare stakeholders, all working towards the common goal of improving patients’ lives.” Jean-Christophe Tellier, CEO @ucb_news at the #EconPatientValue Summit https://t.co/PPvJjo3v54
— UCB News (@ucb_news) 21.02.2019
Highlights
At UCB, we take our responsibility to the planet very seriously.
UCB Ventures is a €150 million strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases. Discove more...
